Background: Uric acid is the final product of purine metabolism and elevated serum urate levels
Introduction
Uric acid is the end breakdown product of purine complex in human beings and high uric acid levels in the blood (hyperuricemia) leads to the deposition of monosodium urate (MSU) crystals in the joints and tissues, which plays a predominant role in the development of gout (Dehghan et al. 2008; Yang et al. 2010; Köttgen et al. 2012; Perez-Ruiz et al. 2014; Dong et al. 2017b) . Gout is one acute inflammatory arthritis (Dong and Wang 2015; Dong et al. 2017a ) and affects a large number of individuals in many countries (Zhu et al. 2011; Dong et al. 2015a) . Hyperuricemia is able to cause gout (Dong et al. 2015b ), but not all hyperuricemia patients develop gout (Merriman 2015) .
Generally, only a quarter of hyperemia patients finally develop gout, indicating that hyperuricemia is necessary but not sufficient for gout (Merriman 2015) . Nowadays, several loci in different genes have been identified to affect serum urate concentration and gout risk (Köttgen et al. 2012; Merriman 2015) . However, those loci only explained a fraction of heredity of serum urate/gout and some of them contribute differently to the pathogenesis from elevated serum urate to hyperuricemia to gout (Köttgen et al. 2012; Dong et al. 2017b) . And epistasis had been proved to affect complex traits and played important roles in various biological functions (Cordell 2002; Phillips 2008) . Therefore, it is urgent to test the effect of epistatic interactions of genes on the development from elevated serum urate to hyperuricemia to gout.
In addition, recent studies found PKD2 associated with uric acid and gout (Zhang et al. 2016 ), while other researchers had an opposite opinion (Dehghan et al. 2008) . The conflicting results for the effect of PKD2 on serum urate levels and gout risk is a challenge topic which need more evidences to obtain a reliable conclusion. In addition, a suggestive epistatic interaction for regulating serum urate concentrations had been reported in the gene region of PKD2 and ABCG2 (Wei et al. 2014) . Therefore, epistasis analysis of PKD2 and ABCG2 might obtain a new evidence for this conflict and provide an explanation to extra heredity of serum urate and gout.
In the present study, we aim to study epistasis between PKD2 and ABCG2 applying a four-step approach. Firstly, the effect of loci interactions on serum urate was studied. Then the candidate urate-related interactions were tested in hyperuricemia and gout patients. Other heterogeneity factors, including gender, body mass index (BMI) and smoking status, influence on above significant associations were also considered in our analysis. In addition, further functional analysis was performed to provide more proof about the interactions. Finally, the relation of mRNA expression between PKD2 and ABCG2 were investigated. Through this strategy, the present study for the first time found that epistatic interactions between PKD2 and ABCG2 contributed to serum urate concentrations and gout risk, and PKD2 might influence the pathogenesis from elevated serum urate to hyperuricemia to gout by modifying ABCG2.
Methods and materials

Study subjects
The present study was approved by the Ethical Committees of the School of Life Sciences of Fudan University (approval number of 140) and was conducted in accordance with the principles of the Declaration of Helsinki. All subjects in this study provided their written informed. All of 582 gout patients were diagnosed with gout (OMIM: #138900) following the American College of Rheumatology diagnostic criteria (Wallace et al. 1977) , came from Changhai Hospital, Taixing People's Hospital and Taizhou People's Hospital. And gout patients did not use any urate-lowering drugs two weeks before sample collection.
Furthermore, 4332 individuals with no history of gout were selected from the Taizhou Longitudinal Study (Wang et al. 2009 ). Those subjects were divided into subgroups based on their smoking status recorded in questionnaires, and body mass index (BMI) values according to the categories of the World Health Organization (WHO) (Yang et al. 2016; Dong et al. 2017b ).
Smoking status contained non-smoker, former smoker and current smoker. Regarding BMI, three subgroups (underweight: BMI < 18.5; normal weight: 18.50 £ BMI < 25; overweight: BMI ³ 25) were divided in this study. Among them, 1387 subjects were treated as hyperuricemia patients due to their high serum urate levels (> 417 umol/L) (Khanna et al. 2012) , and the others were treated as healthy controls. The detail characteristics of the participants in this study are illustrated in Supplementary Material, Table S1 .
SNP genotype and Real-time qPCR
Peripheral blood was collected from all participants in this study and DNA was extracted from blood samples. RNA was isolated from blood cells of 58 male healthy subjects. Detail information of experimental approaches for DNA and RNA had been described in our previous study (Dong et al. 2017b ). Genotyping of SNPs in PKD2 (rs2725215 and rs2728121) and ABCG2 (rs2231137 and rs1481012) was processed by SNaPshot. And the gene relative expression was tested using real-time qPCR.
Bioinformatics analysis
Two PKD2 SNPs sets were used in this study. One (set one) was SNPs associated with serum urate reaching genome-wide significance levels in a recent genome-wide association study (Köttgen et al. 2012) . Another (set two) was all SNPs in the gene region of PKD2. Cell-type-specific enhancer enrichment analysis was performed in both two sets using HaploReg (http://archive.broadinstitute.org/mammals/haploreg/haploreg.php) (Ward and Kellis 2012).
SNPnexus (Dayem Ullah et al. 2013 ) and UCSC genome browser (Kent et al. 2002) were applied for the functional annotation of loci. Enlight (http://enlight.wglab.org) was used to draw regional plot and show epigenetic modification (Guo et al. 2015) . In addition, linkage disequilibrium (LD)
relationships among target SNPs were tested and generated LD plots using SNAP (http://archive.broadinstitute.org/mpg/snap/index.php) (Johnson et al. 2008 ).
Statistical analysis
P-value of SNP pair affected on serum urate concentrations was calculated by linear regression adjusted age, gender and target SNPs. Variance explained of SNP pair in serum urate was calculated by linear regression. And P-value of SNP pair in hyperuricemia and gout were calculated by logistic regression adjusted age, gender and target SNPs. Furthermore, subgroups analysis of gender, BMI and smoking status were also performed. In addition, the mRNA expression correlation between PKD2 and ABCG2 was analyzed in our study. P values less than 0.05 were considered statistically significant and all statistical analyses were processed by using R (Version 3.0.2: www.r-project.org/).
Results
Epistatic interactions of PDK2 and ABCG2 contributed to serum urate concentrations
A total of four SNP pairs were tested in our study. Of them, two SNP pairs (rs2728121:rs1481012 and rs2728121:rs2231137) were identified to associate with the concentrations of serum urate (Estimate = -14.487, P int = 0.018 and Estimate = 9.781, P int = 0.004, respectively), while other pairs did not (P int = 0.181 and P int = 0.270, respectively) ( Table 1 ). The former SNP pair (rs2728121:rs1481012) could explain 0.099% of uric acid variance without conditioning on the marginal SNPs, and the later pair (rs2728121:rs2231137) could explain 0.164% of the variance (Table 1 ).
In addition, the present study showed that the significant association between SNP pairs and serum urate were modified by gender (Table 1) . In males, the latter interaction pair exhibited an effect on uric acid (Estimate = 8.980, P int = 0.017) while the former interaction pair did not (P int = 0.379).
In contrast to female subjects, the former interaction pair contributed to the concentrations of serum urate (Estimate = -33.315, P int = 0.006) while the latter interaction pair did not (P int = 0.171).
Interestingly, the explanation of former interaction pair on uric acid variance achieved 0.493% in female, suggesting an important influence of epistasis between PKD2 and ABCG2 on serum urate.
Epistatic interactions of PDK2 and ABCG2 affected gout risk
Because elevated serum urate is a critical risk factor for the development of hyperuricemia and gout. We further checked the contributions of epistatic interactions of PDK2 and ABCG2 on hyperuricemia and gout. Regards hyperuricemia, the former interaction pair justly affected the hyperuricemia risk in females (Estimate = -0.648, P int = 0.017) ( Table 2 ), but did not in males (P int = 0.483). In opposite of the former pair, the latter pair associated with hyperuricemia in males with P int value of 0.018, but did not in females (P int = 0.427). With combination of males and females, the latter pair also influenced the pathogenesis of hyperuricemia (Estimate = 0.193, P int = 0.009).
For the development from hyperuricemia to gout, the latter pair played an significant role in this translation (Estimate = 0.313, P int = 0.035), especially in males (Estimate = 0.338, P int = 0.030) (Table 2 ). However, the former pair showed not significant association with this translation in both subgroup of male and female (P int = 0.444 and P int = 0.577, respectively). Due to the contribution of the latter pair in the pathogenesis from elevated serum urate to hyperuricemia to gout, it distinctly affected the risk of gout (Estimate = 0.480, P int = 0.001), especially for male individuals (Estimate = 0.524, P int = 0.001).
Association between epistatic interactions and serum urate in BMI and smoking subgroups
Our previous studies have suggested that body mass index (BMI) and cigarette smoking could affect uric acid levels (Dong et al. 2015b (Dong et al. , 2017b Yang et al. 2016) , while their contributions on the association between epistasis and serum urate was elusive. Therefore, we performed further analysis in the BMI and smoking status subgroups.
After analyzed in BMI subgroups, the latter pair was identified to be associated with uric acid in normal subjects (Estimate = 11.456, P int = 0.013) and overweight individuals (Estimate = 9.844, P int = 0.047) ( Table 3 ). And the former pair only affected the concentrations of serum urate in overweight subgroup (Estimate = -21.702, P int = 0.022). However, no significant associations were found in the subgroup of underweight with all P-values larger than 0.05. Regards smoking status, both SNP pairs did not influence uric acid levels (Table 3) .
Functional analysis for identified SNP pairs
Chromatin states analysis was performed in the gene region of PKD2 and ABCG2, showing several strong and weak enhancers located at this region, especially at the gene region of PKD2
(Supplementary material Figure 1 and 2). Consistent with this result, many other functional factors, such as transcription factor and DNase factor, were also identified in PKD2 gene region (Supplementary material Figure 1 and 2). Our results suggested a potential regulate effect in those genes region, especially in PKD2. In addition, ABCG2 had been identified with function as urate transporter in previous studies (Woodward et al. 2009; Köttgen et al. 2012; Dong et al. 2015a ).
Above all, we hypothesized that PKD2 influenced serum urate by epistatic interacting with ABCG2.
To further analyze the regulation function in PKD2 region, two SNP sets in this region were tested using enhancer enrichment analysis (Table 4) . For set one, we found significant enrichments of enhancers in Huvec cell line (3.6-fold enrichment, P = 0.012), especially for strong enhancers (5.7-fold enrichment, P = 0.005) (Table 4) . More significant enhancer enrichments were found for set two and those enrichments were existed in various cell lines (H1, HepG2, Huvec, HSMM, NHLF, HMEC, GM12878 and NHEK cell lines) ( Table 4 ). All those results revealed that regulation factors in PKD2 might played an important role in controlling the concentrations of serum urate by epistatic interacting with ABCG2.
The mRNA expression correlation between PDK2 and ABCG2
To further validate the potential epistatic influence in PKD2 region, the mRNA expression correlation between PKD2 and ABCG2 was studied. Our result showed that PKD2 mRNA expression was positive correlation with ABCG2 mRNA expression (r = 0.743, P = 5.83e-06) (Figure 1 ), suggested the potential effect of regulation factor in PKD2 on modification of ABCG2 expression.
Discussion
This study explored the epistatic interaction between PKD2 and ABCG2 affecting the pathogenesis from elevated serum urate to hyperuricemia to gout and found two SNP pairs (rs2728121:rs1481012 and rs2728121:rs2231137) significantly associated with serum urate and/or gout. The SNP pairs identified in the association study were analyzed in detail, including the analysis of association among subgroups of heterogeneity factors (such as gender, body mass index (BMI) and smoking status), functional analysis and mRNA expression analysis.
ABCG2 gene encoded a urate transporter and contributed to serum urate concentration and gout risk. It had been proved to be one of strongest risk factor for the development of gout (Köttgen et al. 2012; Dong et al. 2015a) . But the results for the association between PKD2 and uric acid/gout is contradictory. Recent studies suggested that PKD2 associated with uric acid and gout (Zhang et al. 2016 ), while other researchers had an opposite opinion (Dehghan et al. 2008 ). In addition, no functional experiment showed that PKD2 directly affect the concentration of serum urate and gout risk. Therefore, this study attempted to provide more evidences to obtain a reliable conclusion.
Previous study had been suggested the important role of epistatic interaction in the 4p16.1 region regulating uric acid levels and showed a suggestive interaction pair in the gene region of PKD2 (Wei et al. 2014) . Therefore, this study focused on the epistasis effect in PKD2 and ABCG2 gene region. The present study showed that two epistatic interaction pairs (rs2728121:rs1481012 and rs2728121:rs2231137) were identified to associate with the concentrations of serum urate (Estimate = -14.487, P int = 0.018 and Estimate = 9.781, P int = 0.004, respectively) and the latter pair (rs2728121: rs2231137) was also associated with gout (P int = 0.001) ( Table 1 and 2). The results provided a new view for explaining the influence of PKD2 on serum urate/gout. PKD2 could contribute to the pathogenesis from elevated serum urate to hyperuricemia to gout by an indirect way as interacting with ABCG2. Although the direct function of PKD2 in influencing the pathogenesis could not identified in this study, it provided a new evidence to state that PKD2 is a urate/gout-associated gene. Our study also found that the former interaction pair could explain 0.099% of uric acid variance especially 0.493% in female, and the later interaction pair could explain 0.164% of the variance (Table 1) , suggesting epistasis effect is helpful to solve the 'missing heritability' problem. In addition, in consistent with our previous results (Dong et al. 2015b (Dong et al. , 2017b Yang et al. 2016) . Environment factors, such as gender and BMI modified the associations between SNP pairs and serum urate/gout in the present study (Table 3 ).
The mechanism of the interactions between genes were analyzed by functional analysis and mRNA expression analysis. The functional analysis showed that regulation factors enrichment into the gene region of PKD2, indicating the potential regulation function of PKD2 to ABCG2. To further analyze this result, mRNA expression correlation between genes was used. The result suggested a positive correlation between PDK2 mRNA expression and ABCG2 mRNA expression, further supporting our hypothesis that PKD2 influenced serum urate by epistatic interacting with ABCG2.
In conclusion, this study for the first time suggested that epistatic interactions between PKD2 and ABCG2 influenced serum urate concentrations and gout risk, and PKD2 might affect the pathogenesis from elevated serum urate to hyperuricemia to gout by modifying ABCG2.
Furthermore, our study provided a new evidence to support that PKD2 is a urate/gout-associated gene and indicated that epistasis effect is helpful to solve the 'missing heritability' problem. 
